M&A Deal Summary |
|
|---|---|
| Date | 2020-09-11 |
| Target | Canopy Biosciences |
| Sector | Life Science |
| Buyer(s) | Bruker |
| Sellers(s) | Ampersand Capital Partners |
| Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1991 |
| Sector | Test/Measurement Equipment |
| Employees | 9,707 |
| Revenue | 3.0B USD (2023) |
Bruker is a provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analysis. Bruker was founded in 1991 and is based in Billerica, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 31 of 47 |
| Sector (Life Science) | 3 of 4 |
| Type (Add-on Acquisition) | 26 of 42 |
| State (Missouri) | 1 of 1 |
| Country (United States) | 14 of 21 |
| Year (2020) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-10-02 |
Magnettech EPR - Business
Germany Magnettech EPR - Business is a provider of the MS 5000 benchtop system and related dedicated EPR analysis solutions, as well as global service and support. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-11-19 |
MOLECUBES
Gent, Belgium MOLECUBES is a manufacturer of molecular imaging instrumentation for preclinical research. MOLECUBES offers a modular benchtop platform, consisting of preclinical PET, SPECT, and CT CUBES imagers. MOLECUBES is based in Gent, Belgium. |
Buy | - |
| Category | Growth Capital Firm |
|---|---|
| Founded | 1988 |
| PE ASSETS | 2.0B USD |
| Size | Large |
| Type | Sector Focused |
Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 41 of 53 |
| Sector (Life Science) | 18 of 24 |
| Type (Add-on Acquisition) | 30 of 38 |
| State (Missouri) | 3 of 3 |
| Country (United States) | 41 of 50 |
| Year (2020) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-04-21 |
Tjoapack Netherlands
Etten-Leur, Netherlands Tjoapack is a contract packager of medicines servicing clients across five continents and 42 countries. The CPO specializes in primary packaging for solid dosage forms, secondary packaging, and unit dose packaging and now has a total of 19 packaging lines for blisters, wallets, and bottles. Using these lines, it packages around 26 million packs of pharmaceutical products per year, which equates to around 1.4 billion tablets. Tjoapack was founded in 1989 and is based in Etten-Leur, Netherlands. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-09-21 |
ALPCO
Salem, New Hampshire, United States ALPCO is an importer and distributor of immunoassay-based products for the North American life science markets. ALPCO is a provider of proprietary and distributed diagnostics solutions, with over 60 collaborating partners from around the globe. ALPCO was founded in 1990 and is based in Salem, New Hampshire. |
Buy | - |
